1-(2-OXO-2-PYRROLIDIN-1-YL-ETHYL)-1H-INDOLE-3-CARBALDEHYDE
![]() |
- $200 - $874
- Product name: 1-(2-OXO-2-PYRROLIDIN-1-YL-ETHYL)-1H-INDOLE-3-CARBALDEHYDE
- CAS: 347320-40-5
- MF: C15H16N2O2
- MW: 256.3
- EINECS:
- MDL Number:MFCD02374077
- Synonyms:1-(2-OXO-2-PYRROLIDIN-1-YL-ETHYL)-1H-INDOLE-3-CARBALDEHYDE;TIMTEC-BB SBB012005;1H-Indole-3-carboxaldehyde, 1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-;1-[2-Oxo-2-(1-pyrrolidinyl)ethyl]-1h-indole-3-carbaldehyde
4 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerChemenu
- Product numberCM258453
- Product description1-(2-Oxo-2-(pyrrolidin-1-yl)ethyl)-1H-indole-3-carbaldehyde 95%+
- Packaging5g
- Price$825
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11138922
- Product description1-(2-Oxo-2-(pyrrolidin-1-yl)ethyl)-1H-indole-3-carbaldehyde 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number016701
- Product description1-(2-Oxo-2-pyrrolidin-1-yl-ethyl)-1H-indole-3-carbaldehyde
- Packaging500mg
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number016701
- Product description1-(2-Oxo-2-pyrrolidin-1-yl-ethyl)-1H-indole-3-carbaldehyde
- Packaging1g
- Price$308
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM258453 | 1-(2-Oxo-2-(pyrrolidin-1-yl)ethyl)-1H-indole-3-carbaldehyde 95%+ | 5g | $825 | 2021-12-16 | Buy |
Crysdot | CD11138922 | 1-(2-Oxo-2-(pyrrolidin-1-yl)ethyl)-1H-indole-3-carbaldehyde 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 016701 | 1-(2-Oxo-2-pyrrolidin-1-yl-ethyl)-1H-indole-3-carbaldehyde | 500mg | $200 | 2021-12-16 | Buy |
Matrix Scientific | 016701 | 1-(2-Oxo-2-pyrrolidin-1-yl-ethyl)-1H-indole-3-carbaldehyde | 1g | $308 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|